IRIS
BARISON, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.097
AS - Asia 5.778
EU - Europa 5.743
SA - Sud America 1.271
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
Totale 23.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.564
SG - Singapore 2.098
IT - Italia 1.518
RU - Federazione Russa 1.472
CN - Cina 1.419
BR - Brasile 990
VN - Vietnam 867
GB - Regno Unito 855
DE - Germania 570
HK - Hong Kong 392
BD - Bangladesh 357
CA - Canada 353
UA - Ucraina 298
FR - Francia 224
FI - Finlandia 161
SE - Svezia 139
IN - India 136
MX - Messico 121
DK - Danimarca 118
AR - Argentina 107
PL - Polonia 91
TR - Turchia 77
ES - Italia 67
ID - Indonesia 65
IL - Israele 64
NL - Olanda 63
ZA - Sudafrica 59
IQ - Iraq 58
EC - Ecuador 56
IE - Irlanda 51
JP - Giappone 45
CO - Colombia 29
UZ - Uzbekistan 27
AT - Austria 25
MA - Marocco 23
PK - Pakistan 23
VE - Venezuela 23
AE - Emirati Arabi Uniti 21
PY - Paraguay 19
EG - Egitto 16
SA - Arabia Saudita 16
MY - Malesia 15
CL - Cile 14
LT - Lituania 14
JO - Giordania 12
CH - Svizzera 11
EU - Europa 11
PE - Perù 11
TN - Tunisia 11
UY - Uruguay 11
JM - Giamaica 9
KE - Kenya 9
CR - Costa Rica 8
HN - Honduras 8
PH - Filippine 8
AU - Australia 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
KZ - Kazakistan 7
BE - Belgio 6
CZ - Repubblica Ceca 6
GR - Grecia 6
IR - Iran 6
NI - Nicaragua 6
NP - Nepal 6
PS - Palestinian Territory 6
BH - Bahrain 5
GY - Guiana 5
HR - Croazia 5
KG - Kirghizistan 5
LB - Libano 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BB - Barbados 4
BO - Bolivia 4
BY - Bielorussia 4
ET - Etiopia 4
PT - Portogallo 4
RO - Romania 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TH - Thailandia 4
CG - Congo 3
HU - Ungheria 3
KR - Corea 3
KW - Kuwait 3
LV - Lettonia 3
MD - Moldavia 3
OM - Oman 3
RS - Serbia 3
SM - San Marino 3
SN - Senegal 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GE - Georgia 2
GP - Guadalupe 2
GT - Guatemala 2
KH - Cambogia 2
Totale 23.017
Salva come PNG Salva come JPEG
Città #
Dallas 1.527
Singapore 1.098
Ashburn 711
San Jose 655
Beijing 602
Southend 444
Los Angeles 374
Hong Kong 358
Chicago 350
Houston 323
Chandler 314
Moscow 287
Ho Chi Minh City 265
Fairfield 252
Ann Arbor 242
New York 231
Woodbridge 225
San Mateo 200
Milan 178
Hanoi 162
Wilmington 159
Seattle 152
Rome 141
Buffalo 138
Salt Lake City 132
Cambridge 130
The Dalles 130
Falls Church 129
São Paulo 116
Santa Clara 115
Jacksonville 112
Council Bluffs 109
Dearborn 108
Ottawa 101
Boardman 95
Pisa 93
Tampa 93
Hefei 91
Lauterbourg 91
Helsinki 90
Portsmouth 79
Stevenage 79
Warsaw 78
Munich 72
Montreal 70
Dong Ket 68
Brooklyn 67
London 66
Columbus 63
Elk Grove Village 61
Mexico City 61
Orem 61
Lawrence 57
Beauharnois 56
Tel Aviv 55
Dublin 49
Denver 47
Toronto 44
Florence 43
Istanbul 43
Frankfurt am Main 42
Johannesburg 41
Tokyo 40
Chennai 39
San Diego 39
Stockholm 39
Atlanta 37
Phoenix 36
Sterling 35
Lancaster 34
Rio de Janeiro 34
Poplar 32
Amsterdam 31
Boston 29
Da Nang 28
Campinas 27
Tashkent 26
Turku 26
Guayaquil 24
Haiphong 24
Palermo 24
Bari 23
Miami 23
Naples 23
Figino 22
Lappeenranta 22
Redwood City 22
Turin 22
Central District 21
Montréal 21
Mumbai 21
Nuremberg 21
Genoa 20
San Francisco 19
Belo Horizonte 18
Biên Hòa 18
Ankara 17
Baghdad 17
Dulles 17
Manchester 17
Totale 13.413
Salva come PNG Salva come JPEG
Nome #
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.576
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 696
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 450
A simple echocardiographic score to rule out cardiac amyloidosis 387
A simple echocardiographic score to rule out cardiac amyloidosis 354
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 353
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 334
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 330
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 330
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 326
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 323
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 318
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 315
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 314
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 314
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 306
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 304
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 303
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 300
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 300
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 295
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 286
Sex-related differences in chronic heart failure 280
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 279
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 269
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 269
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 268
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 260
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 259
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 259
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 258
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 258
Update sui biomarcatori nello scompenso cardiaco. 257
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 254
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 253
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 241
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 241
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 238
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 238
Cardiac magnetic resonance in patients with muscular dystrophies 238
Role of Imaging in Cardiomyopathies 235
Valvular heart disease in patients with cardiac amyloidosis 235
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 235
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 235
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 231
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 229
Cardiovascular disease and COVID-19: les liaisons dangereuses 227
Perspectives in noninvasive imaging for chronic coronary syndromes 225
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 218
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 216
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 215
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 214
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 213
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 213
Molecular autopsy of sudden cardiac death in the genomics era 213
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 210
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 210
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 208
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 206
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 205
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 199
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 198
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 196
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 194
Colchicine for the treatment of coronary artery disease 193
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 191
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 190
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 188
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 184
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 184
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 171
Multimodality Imaging in a Patient With MINOCA and Anomalous Coronary Artery 171
Troponin in non-ischaemic dilated cardiomyopathy 170
Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry 163
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 159
Treatment of cardiac transthyretin amyloidosis: an update 158
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 156
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 156
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 156
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 153
Partial Lipodystrophy and LMNA p.R545H Variant 152
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 147
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 134
The Barthel Index in elderly acute heart failure patients. Frailty matters 133
The unbearable underreporting of comorbidities in heart failure clinical trials 131
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 128
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 128
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 115
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 115
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 101
European task force reclassification of dilated and non-dilated cardiomyopathies identifies a high arrhythmic-risk overlap phenotype 89
Prognostic role of updated Lake Louise criteria for the diagnosis of acute myocarditis (ITAMY-mapping study) 69
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 64
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 58
Photon-Counting Computed Tomography for Tissue Characterization in Patients With a Left Ventricular Hypertrophic Phenotype 51
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 44
A Novel SCN5A Missense Variant Associated With Familial Non-Dilated Left Ventricular Cardiomyopathy 39
Electrocardiographic abnormalities in patients with cardiomyopathies 36
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 30
null 29
Totale 23.149
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.065
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 0 0 0 0 0 0 193
2021/20221.102 122 166 37 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024532 41 18 107 57 22 51 48 23 12 14 21 118
2024/20255.130 45 54 208 67 166 214 505 970 327 915 932 727
2025/202612.028 736 1.666 1.365 1.555 1.265 769 1.052 612 762 826 810 610
Totale 23.211